The findings that CAPG knockdown led to decreased levels of TGFB1 and its downstream effectors, Smad2/3, indicate that CAPG may contribute to Dox resistance via the TGFB1/Smad2/3/Nrf2 signalling pathway in HCC cells. The gene discussed is CAPG; the disease is hepatocellular carcinoma.